Buy LuciFine 10 mg (Finerenone) – Generic Kerendia for CKD in Type 2 Diabetes

LuciFine 10 mg contains finerenone, a non-steroidal mineralocorticoid receptor antagonist (MRA) manufactured by Lucius Pharmaceuticals (Laos). It’s indicated for adults with chronic kidney disease (CKD) associated with type 2 diabetes to slow eGFR decline, and reduce risk of kidney failure, cardiovascular death, myocardial infarction, and hospitalization for heart failure. 

How It Works

Finerenone blocks mineralocorticoid receptors, reducing inflammation and scarring in kidneys and blood vessels. This helps protect renal function and lowers heart-related risks. 

Clinical Uses & Benefits

• Reduces risk of kidney disease progression, end‑stage kidney disease, heart attacks, and heart failure hospitalization in CKD with T2D. 
• Approved for adult CKD patients associated with type 2 diabetes; latest data suggests use in heart failure with LVEF ≥40%.

Dosage & Administration

• Initial dosage: 10 mg once daily for patients with eGFR 25–59 mL/min/1.73 m²; 20 mg once daily for eGFR ≥ 60.
• Target dose: 20 mg once daily if tolerated, with potassium and renal monitoring at 4 weeks. 
• Take with or without food, at the same time daily. Tablets may be crushed and mixed with water or soft food if swallowing is difficult.

Side Effects & Safety

• Common: hyperkalemia (high potassium), hypotension, hyponatremia—monitor labs regularly.
• Other: dizziness, fatigue, headache. Rare: allergic reactions.
• Contraindications: adrenal insufficiency, baseline serum potassium >5.0 mEq/L, strong CYP3A4 inhibitors, pregnancy, or breastfeeding.

Drug Interactions & Precautions

• Avoid strong CYP3A4 inhibitors (e.g. ketoconazole, clarithromycin). Moderate inhibitors may require dose adjustments.
• High potassium risk with potassium-sparing diuretics, NSAIDs, aldosterone antagonists—monitor closely. 
• Not recommended in severe liver impairment or adrenal gland disorders. 

Global Availability & Prescription Info

LuciFine 10 mg is prescription-only. Manufactured by Lucius Pharmaceuticals (Laos) and available internationally via licensed pharmacies with discreet packaging and tracking. Medical supervision is essential.

📌 Frequently Asked Questions (FAQs)

1. What does LuciFine 10 mg treat?

It’s used to slow kidney function decline and reduce cardiovascular risk in adults with type 2 diabetes and CKD.

2. What is the starting dose?

For eGFR ≥60: start at 20 mg once daily. For eGFR 25–59: start at 10 mg daily, then increase to 20 mg if tolerated.

3. What side effects can occur?

Watch for high potassium, low sodium, low blood pressure; also dizziness, fatigue. Serious reactions are uncommon.

4. What interactions should I know?

Avoid strong CYP3A4 inhibitors and potassium-elevating drugs. Monitor electrolytes before and during treatment.

5. Is it safe during pregnancy or breastfeeding?

No—finerenone is not recommended during pregnancy or breastfeeding. Also avoid in patients with adrenal disorders or baseline hyperkalemia.